Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways

Twenty-eight neoflavonoids have been prepared and evaluated in vitro against HIV-1. Antiviral activity was assessed on MT-2 cells infected with viral clones carrying the luciferase reporter gene. Inhibition of HIV transcription and Tat function were tested on cells stably transfected with the HIV-LT...

Descripción completa

Detalles Bibliográficos
Autores: Olmedo, Dionisio A., López-Pérez, José Luis, del Olmo, Esther, Bedoya Del Olmo, Luis Miguel, Sancho, Rocío, Alcamí, José, Muñoz, Eduardo, San Feliciano, Arturo, Gupta, Mahabir P.
Tipo de recurso: artículo
Fecha de publicación:2017
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/19242
Acceso en línea:https://hdl.handle.net/20.500.14352/19242
Access Level:acceso abierto
Palabra clave:615.011
Neoflavonoids
4-phenyl-chromen-one
AIDS
Tat protein
NF-κB inhibition
Anti-HIV activity
Farmacología (Farmacia)
Química farmaceútica
3209 Farmacología
2390 Química Farmacéutica
id ES_e73e4c10d866c0c15134f7feec2360d4
oai_identifier_str oai:docta.ucm.es:20.500.14352/19242
network_acronym_str ES
network_name_str España
repository_id_str
spelling Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB PathwaysOlmedo, Dionisio A.López-Pérez, José Luisdel Olmo, EstherBedoya Del Olmo, Luis MiguelSancho, RocíoAlcamí, JoséMuñoz, EduardoSan Feliciano, ArturoGupta, Mahabir P.615.011Neoflavonoids4-phenyl-chromen-oneAIDSTat proteinNF-κB inhibitionAnti-HIV activityFarmacología (Farmacia)Química farmaceútica3209 Farmacología2390 Química FarmacéuticaTwenty-eight neoflavonoids have been prepared and evaluated in vitro against HIV-1. Antiviral activity was assessed on MT-2 cells infected with viral clones carrying the luciferase reporter gene. Inhibition of HIV transcription and Tat function were tested on cells stably transfected with the HIV-LTR and Tat protein. Seven 4-phenylchromen-2 one derivatives showed HIV transcriptional inhibitory activity but only the phenylchrome-2-one 10 inhibited NF-κB and displayed anti-Tat activity simultaneously. Compounds 10, 14, and 25, inhibited HIV replication in both targets at concentrations <25 µM. The assays of these synthetic 4 phenylchromen-2-ones may aid in the investigation of some aspects of the anti-HIV activity of such compounds and could serve as a scaffold for designing better anti-HIV compounds, which may lead to a potential anti-HIV therapeutic drug.MDPIUniversidad Complutense de Madrid20172017-02-1920172017-02-19journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.14352/19242reponame:Docta Complutenseinstname:Universidad Complutense de Madrid (UCM)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Atribución 3.0 Españahttps://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:docta.ucm.es:20.500.14352/192422026-06-02T12:44:21Z
dc.title.none.fl_str_mv Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways
title Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways
spellingShingle Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways
Olmedo, Dionisio A.
615.011
Neoflavonoids
4-phenyl-chromen-one
AIDS
Tat protein
NF-κB inhibition
Anti-HIV activity
Farmacología (Farmacia)
Química farmaceútica
3209 Farmacología
2390 Química Farmacéutica
title_short Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways
title_full Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways
title_fullStr Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways
title_full_unstemmed Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways
title_sort Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways
dc.creator.none.fl_str_mv Olmedo, Dionisio A.
López-Pérez, José Luis
del Olmo, Esther
Bedoya Del Olmo, Luis Miguel
Sancho, Rocío
Alcamí, José
Muñoz, Eduardo
San Feliciano, Arturo
Gupta, Mahabir P.
author Olmedo, Dionisio A.
author_facet Olmedo, Dionisio A.
López-Pérez, José Luis
del Olmo, Esther
Bedoya Del Olmo, Luis Miguel
Sancho, Rocío
Alcamí, José
Muñoz, Eduardo
San Feliciano, Arturo
Gupta, Mahabir P.
author_role author
author2 López-Pérez, José Luis
del Olmo, Esther
Bedoya Del Olmo, Luis Miguel
Sancho, Rocío
Alcamí, José
Muñoz, Eduardo
San Feliciano, Arturo
Gupta, Mahabir P.
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidad Complutense de Madrid
dc.subject.none.fl_str_mv 615.011
Neoflavonoids
4-phenyl-chromen-one
AIDS
Tat protein
NF-κB inhibition
Anti-HIV activity
Farmacología (Farmacia)
Química farmaceútica
3209 Farmacología
2390 Química Farmacéutica
topic 615.011
Neoflavonoids
4-phenyl-chromen-one
AIDS
Tat protein
NF-κB inhibition
Anti-HIV activity
Farmacología (Farmacia)
Química farmaceútica
3209 Farmacología
2390 Química Farmacéutica
description Twenty-eight neoflavonoids have been prepared and evaluated in vitro against HIV-1. Antiviral activity was assessed on MT-2 cells infected with viral clones carrying the luciferase reporter gene. Inhibition of HIV transcription and Tat function were tested on cells stably transfected with the HIV-LTR and Tat protein. Seven 4-phenylchromen-2 one derivatives showed HIV transcriptional inhibitory activity but only the phenylchrome-2-one 10 inhibited NF-κB and displayed anti-Tat activity simultaneously. Compounds 10, 14, and 25, inhibited HIV replication in both targets at concentrations <25 µM. The assays of these synthetic 4 phenylchromen-2-ones may aid in the investigation of some aspects of the anti-HIV activity of such compounds and could serve as a scaffold for designing better anti-HIV compounds, which may lead to a potential anti-HIV therapeutic drug.
publishDate 2017
dc.date.none.fl_str_mv 2017
2017-02-19
2017
2017-02-19
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/20.500.14352/19242
url https://hdl.handle.net/20.500.14352/19242
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Atribución 3.0 España
https://creativecommons.org/licenses/by/3.0/es/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Atribución 3.0 España
https://creativecommons.org/licenses/by/3.0/es/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Docta Complutense
instname:Universidad Complutense de Madrid (UCM)
instname_str Universidad Complutense de Madrid (UCM)
reponame_str Docta Complutense
collection Docta Complutense
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869422837390901248
score 15,301603